Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases.
Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
Every minute counts
18 Lives Lost
1,000 Lives Lost
26,000+ Lives Lost
800,000 Lives Lost
We are driven by this urgency. Each minute is an opportunity to make a difference.
12018 World Health Organization International Agency for Research on Cancer (IARC) Cancer Fact Sheet.
Calculated from the WHO IARC global mortality statistic in the 2018 Cancer Fact Sheet
Cancer is responsible for an estimated 9.6 million deaths in 2018.